Diabetogenicity of Cyclosporine and Tacrolimus.

Trial Profile

Diabetogenicity of Cyclosporine and Tacrolimus.

Phase of Trial: Phase IV

Latest Information Update: 26 Jun 2013

At a glance

  • Drugs Ciclosporin (Primary) ; Ciclosporin (Primary) ; Tacrolimus (Primary) ; Tacrolimus (Primary)
  • Indications Renal transplant rejection
  • Focus Pharmacodynamics
  • Acronyms CSATAC
  • Most Recent Events

    • 10 Jun 2017 Biomarkers information updated
    • 07 Nov 2011 Actual end date (Nov 2011) added as reported by ClinicalTrials.gov.
    • 07 Nov 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top